tiprankstipranks
Trending News
More News >
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Israel Market

Teva (TEVA) Income Statement

Compare
48 Followers

Teva Income Statement

Last quarter (Q4 2025), Teva's total revenue was $4.81B, an increase of 13.69% from the same quarter last year. In Q4, Teva's net income was $489.90M. See Teva’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 18.68B$ 16.54B$ 15.85B$ 14.93B$ 15.88B
Gross Profit
$ 9.63B$ 8.06B$ 7.65B$ 6.97B$ 7.59B
Operating Expenses
$ 5.35B$ 8.37B$ 7.21B$ 4.28B$ 4.50B
Depreciation and Amortization
$ 1.08B$ 1.06B$ 1.15B$ 1.31B$ 1.33B
EBITDA
$ 3.42B$ 777.00M$ 1.56B$ -925.00M$ 2.88B
Operating Income
$ 4.28B$ -303.00M$ 433.00M$ -2.10B$ 1.72B
Other Income/Expenses
$ -2.94B$ -981.00M$ -1.05B$ -966.00M$ -1.05B
Pretax Income
$ 1.34B$ -1.28B$ -622.00M$ -3.06B$ 658.00M
Net Income
$ 1.53B$ -1.64B$ -559.00M$ -2.35B$ 417.00M
Per Share Metrics
Basic EPS
$ 1.33$ -1.45$ -0.50$ -2.12$ 0.38
Diluted EPS
$ 1.31$ -1.45$ -0.50$ -2.12$ 0.38
Weighted Average Shares Outstanding
1.15B 1.13B 1.12B 1.11B 1.10B
Weighted Average Shares Outstanding (Diluted)
1.16B 1.13B 1.12B 1.11B 1.11B
Currency in USD

Teva Earnings and Revenue History